Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nidhi Dani"'
Autor:
Vikalp Kumar Maheshwari, Cassandra Slader, Nidhi Dani, Christina Gkitzia, Quan Yuan, Tengbin Xiong, Yu Liu, Ricardo Viana
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Objective To determine the cost effectiveness of molecular monitoring in patients with chronic myeloid leukemia in the chronic phase (CML-CP) compared to no molecular monitoring from a Chinese payer perspective. Methods Analyses were conducted using
Externí odkaz:
https://doaj.org/article/9736bccd0e28441da05c8d7f160fa01a
Autor:
A Adlette Inati, M Maha Sabbagh, C Chadi Al Alam, A Ammar Al Kheir, Z Ziad Massouh, R Rawan Demachkie, C Cristel Ojaimy, N Nidhi Dani, A Asif Siddiqui, R Rishi Rajat Adhikary, B Brendan Lynch, A Abhishek Srivastava
Publikováno v:
HemaSphere, Vol 6, Pp 30-31 (2022)
Externí odkaz:
https://doaj.org/article/76db62833c9d4e87bdfe978c659438e8
Autor:
Tengbin Xiong, Quan Yuan, Christina Gkitzia, Cassandra Slader, Vikalp Kumar Maheshwari, Nidhi Dani, Yu Liu, Ricardo Viana
Publikováno v:
PLoS ONE, Vol 16, Iss 10, p e0259076 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
Objective To determine the cost effectiveness of molecular monitoring in patients with chronic myeloid leukemia in the chronic phase (CML-CP) compared to no molecular monitoring from a Chinese payer perspective. Methods Analyses were conducted using
Publikováno v:
Blood. 134:5867-5867
Background: Sickle cell disease (SCD) is a group of hereditary hemolytic disorders characterized by abnormal hemoglobin molecules that distort red blood cells (RBCs) into a rigid, sickle-like shape. The global burden of SCD is substantial. In North A
Autor:
Adlette Inati, A, Maha Sabbagh, M, Chadi Al Alam, C, Ammar Al Kheir, A, Ziad Massouh, Z, Rawan Demachkie, R, Cristel Ojaimy, C, Nidhi Dani, N, Asif Siddiqui, A, Rishi Rajat Adhikary, R, Brendan Lynch, B, Abhishek Srivastava, A
Publikováno v:
HemaSphere; Jan2022 Supplement 1, Vol. 6, p30-31, 2p